Doxycycline as a sclerosing agent.
Gericke
K R
KR
Division of Clinical Pharmacy, University of California, San Francisco 94123.
D001761:Bleomycin / Q000191:economics / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use*; D006801:Humans; D016066:Pleural Effusion, Malignant / Q000628:therapy*; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015911:Sclerotherapy; D013627:Talc / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D012597:Sclerosing Solutions; D001761:Bleomycin; D013627:Talc; D013752:Tetracycline; D004318:Doxycycline